FdaApplication
NDA 021671
Identifiers
- fda_app_no: NDA021671
Properties
| Property | Value |
|---|---|
| applicant_name | PACIRA PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2004-05-18 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DEPODUR | MORPHINE SULFATE | 10MG/ML (10MG/ML) | INJECTABLE, LIPOSOMAL;EPIDURAL |
| DEPODUR | MORPHINE SULFATE | 20MG/2ML (10MG/ML) | INJECTABLE, LIPOSOMAL;EPIDURAL |
| DEPODUR | MORPHINE SULFATE | 15MG/1.5ML (10MG/ML) | INJECTABLE, LIPOSOMAL;EPIDURAL |
3 products